Aids-related Burkitt Lymphoma
📧 Sign up to get email alerts when something new happens for Aids-related Burkitt Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating Dose Adjusted EPOCH combined with either ofatumumab or rituximab in newly diagnosed or relapsed/refractory Burkitt …
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma [Phase 1]
A Phase 1 study evaluating Bryostatin 1 in combination with Vincristine for recurrent or refractory AIDS-related lymphomas has been complete…